CNS5:Volunteer Assignments and Opportunities: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m due date |
||
| (14 intermediate revisions by 4 users not shown) | |||
| Line 121: | Line 121: | ||
|Laveniya Satgunaseelan | |Laveniya Satgunaseelan | ||
| | | | ||
| | | | ||
| | |COMPLETE | ||
| | | | ||
|LS | |LS | ||
| Line 174: | Line 174: | ||
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]] | |[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]] | ||
|Disease | |Disease | ||
|Layla Zhu | |||
|<br />3/2/2026 | |||
| | | | ||
| | |PENDING | ||
| | | | ||
|LS | |LS | ||
| Line 185: | Line 185: | ||
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]] | |[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]] | ||
|Disease | |Disease | ||
|Wahab Khan | |||
|2/8/2026 | |||
| | | | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 199: | Line 199: | ||
|15/04/2025 | |15/04/2025 | ||
| | | | ||
| | |COMPLETE | ||
|2/8/2026 (Feb 8) | |||
|LS | |LS | ||
| | | | ||
| Line 229: | Line 229: | ||
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]] | |[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]] | ||
|Disease | |Disease | ||
|Milana.Djonovic (trainee), Laveniya/Madina | |||
|4/26/2026 | |||
|6/15/2026 | |||
|PENDING | |||
| | | | ||
| | |LS | ||
| | | | ||
| | | | ||
| Line 416: | Line 416: | ||
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]] | |[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]] | ||
|Disease | |Disease | ||
|Laveniya Satgunaseelan | |||
|2/4/2026 | |||
|30/6/2026 | |||
|PENDING | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
|- | |||
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]] | |||
|Disease | |||
|Laveniya Satgunaseelan | |||
|- | |2/4/2026 | ||
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]] | |30/6/2026 | ||
|Disease | |PENDING | ||
| | |||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
| Line 438: | Line 438: | ||
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]] | |[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]] | ||
|Disease | |Disease | ||
| | |Laveniya Satgunaseelan | ||
| | |2/4/2026 | ||
| | |30/6/2026 | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 640: | Line 640: | ||
|Pending | |Pending | ||
| | | | ||
| | |MS | ||
| | | | ||
| | | | ||
| Line 801: | Line 801: | ||
|Fang Fang (trainee)+Katie Schieffer (mentor) | |Fang Fang (trainee)+Katie Schieffer (mentor) | ||
|11/19/2025 | |11/19/2025 | ||
| | |6/15/2026 | ||
|Pending | |Pending | ||
| | | | ||
| Line 853: | Line 853: | ||
|[[CNS5:Schwannoma|Schwannoma]] | |[[CNS5:Schwannoma|Schwannoma]] | ||
|Disease | |Disease | ||
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]] | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
| | | | ||
|- | |||
|- | |||
|[[CNS5:Neurofibroma|Neurofibroma]] | |[[CNS5:Neurofibroma|Neurofibroma]] | ||
|Disease | |Disease | ||
| | |[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Perineurioma|Perineurioma]] | |[[CNS5:Perineurioma|Perineurioma]] | ||
|Disease | |Disease | ||
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]] | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
| | | | ||
|- | |||
|- | |||
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]] | |[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]] | ||
|Disease | |Disease | ||
| | |[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]] | |[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]] | ||
|Disease | |Disease | ||
| | |[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
| Line 919: | Line 919: | ||
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]] | |[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]] | ||
|Disease | |Disease | ||
| | |[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
| Line 994: | Line 994: | ||
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]] | |[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]] | ||
|Disease | |Disease | ||
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]] | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
| | | | ||
|- | |||
|- | |||
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]] | |[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]] | ||
|Disease | |Disease | ||
| Line 1,060: | Line 1,060: | ||
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]] | |[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]] | ||
|Disease | |Disease | ||
| | |[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
| Line 1,082: | Line 1,082: | ||
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]] | |[[CNS5:Ewing_sarcoma|Ewing sarcoma]] | ||
|Disease | |Disease | ||
| | |[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]] | |[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]] | ||
|Disease | |Disease | ||
| | |[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
| Line 1,223: | Line 1,223: | ||
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]] | |[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]] | ||
|Disease | |Disease | ||
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]] | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
| | | | ||
|- | |||
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]] | |||
|Disease | |||
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]] | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
| | | | ||
| | |- | ||
| | |[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]] | ||
| | |Disease | ||
| | |[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
| | | | ||
|- | |- | ||
|[[CNS5: | |[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,243: | Line 1,265: | ||
| | | | ||
|- | |- | ||
|[[CNS5: | |[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]] | ||
|Disease | |Disease | ||
|Jennie Thurston | |||
|Jennie Thurston | |||
|7/2/2023 | |7/2/2023 | ||
| | | | ||
| Line 1,289: | Line 1,289: | ||
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]] | |[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]] | ||
|Disease | |Disease | ||
| | |[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]] | |[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]] | ||
|Disease | |Disease | ||
| | |[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]] | |[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]] | ||
|Disease | |Disease | ||
| | |[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
| Line 1,333: | Line 1,333: | ||
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]] | |[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]] | ||
|Disease | |Disease | ||
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]] | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
| | | | ||
|- | |||
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]] | |||
|Disease | |||
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]] | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
| | | | ||
|- | |||
| | | | ||
====CHAPTER 11 (GERM CELL TUMOURS)==== | |||
| | | | ||
---- | |||
| | | | ||
---- | |||
---- | |||
| | | | ||
---- | ---- | ||
| Line 1,545: | Line 1,545: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]] | |[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]] | ||
| Line 1,556: | Line 1,556: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Schwannomatosis|Schwannomatosis]] | |[[CNS5:Schwannomatosis|Schwannomatosis]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
| Line 1,578: | Line 1,578: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]] | |[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]] | ||
|Disease | |Disease | ||
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| Line 1,600: | Line 1,589: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
|N/A | | | ||
|- | |||
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] | |||
|Disease | |||
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
| | |||
|- | |- | ||
!'''Disease''' | !'''Disease''' | ||
| Line 1,615: | Line 1,615: | ||
|[[CNS5:Cowden_syndrome|Cowden syndrome]] | |[[CNS5:Cowden_syndrome|Cowden syndrome]] | ||
|Disease | |Disease | ||
|[[ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| Line 1,623: | Line 1,622: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | |||
|- | |- | ||
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]] | |[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]] | ||
| Line 1,633: | Line 1,633: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]] | |[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]] | ||
| Line 1,644: | Line 1,644: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]] | |[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]] | ||
|Disease | |Disease | ||
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
| | | | ||
|- | |||
|- | |||
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]] | |[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Carney_complex|Carney complex]] | |[[CNS5:Carney_complex|Carney complex]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
| Line 1,688: | Line 1,688: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]] | |[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]] | |[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
| Line 1,730: | Line 1,730: | ||
!'''Author Content (Pending or Complete)''' | !'''Author Content (Pending or Complete)''' | ||
!'''Date Completed by Author''' | !'''Date Completed by Author''' | ||
!'''Associate Editor''' | !'''Associate Editor''' | ||
!'''Date of Last Editor Review''' | !'''Date of Last Editor Review''' | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]] | |[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]] | ||
|Disease | |Disease | ||
| | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | |N/A | ||
| | | | ||
|- | |- | ||
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]] | |[[CNS5:Fanconi_anaemia|Fanconi anaemia]] | ||
|Disease | |||
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
|N/A | |||
| | |||
|- | |||
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]] | |||
|Disease | |Disease | ||
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
| Line 1,754: | Line 1,765: | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
| | | | ||
|- | |- | ||
|} | |} | ||
Latest revision as of 11:05, 28 April 2026
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
|---|---|---|---|---|---|---|---|---|---|
CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS) |
|
|
|
|
|
|
|
|
|
| Astrocytoma, IDH-mutant | Disease | Meenakshi Mehrotra | 6/25/2023 | COMPLETE | Laveniya Satgunaseelan (LS) | 2021 template added | |||
| Oligodendroglioma, IDH-mutant and 1p/19q-codeleted | Disease | Riley Lochner (trainee);
Shashi Shetty (mentor) |
6/7/2022 | COMPLETE | LS | 2021 template added | |||
| Glioblastoma, IDH-wildtype | Disease | Jieying Wu | 11/18/2025 | 01/15/2026 | PENDING | LS | Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added | ||
| Diffuse astrocytoma, MYB- or MYBL1-altered | Disease | Scott Smith | 6/27/2023 | COMPLETE | LS | 2021 template added (page created 6/27/23) | |||
| Angiocentric glioma | Disease | ||||||||
| Polymorphous low-grade neuroepithelial tumour of the young | Disease | ||||||||
| Diffuse low-grade glioma, MAPK pathway-altered | Disease | Scott Smith | 5/3/2024 | PENDING - email reminder 9/4/2025 | LS | ||||
| Diffuse midline glioma, H3 K27-altered | Disease | Laveniya Satgunaseelan | COMPLETE | LS | 2021 template added | ||||
| Diffuse hemispheric glioma, H3 G34-mutant | Disease | Xiaolin (Lynn) Hu | 2/21/2022 | COMPLETE | LS | 2021 template added | |||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype | Disease | Madina Sukhanova | 10/28/2022 | COMPLETE | LS | 2021 template added | |||
| Infant-type hemispheric glioma | Disease | ||||||||
| Pilocytic astrocytoma | Disease | Layla Zhu | 3/2/2026 |
PENDING | LS | 2021 template added | |||
| High-grade astrocytoma with piloid features | Disease | Wahab Khan | 2/8/2026 | PENDING | |||||
| Pleomorphic xanthoastrocytoma | Disease | Wahab Khan | 15/04/2025 | COMPLETE | 2/8/2026 (Feb 8) | LS | 2021 template added | ||
| Subependymal giant cell astrocytoma | Disease | ||||||||
| Chordoid glioma | Disease | ||||||||
| Astroblastoma, MN1-altered | Disease | Milana.Djonovic (trainee), Laveniya/Madina | 4/26/2026 | 6/15/2026 | PENDING | LS | |||
| Ganglioglioma | Disease | Leila Moayed-Aloei | 6/30/2022 | COMPLETE | LS | 2021 template added | |||
| Gangliocytoma | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma | Disease | ||||||||
| Dysembryoplastic neuroepithelial tumour | Disease | ||||||||
| Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters | Disease | ||||||||
| Papillary glioneuronal tumour | Disease | ||||||||
| Rosette-forming glioneuronal tumour | Disease | ||||||||
| Myxoid glioneuronal tumour | Disease | ||||||||
| Diffuse leptomeningeal glioneuronal tumour | Disease | Laveniya Satgunaseelan | 9/11/2024 | COMPLETE | 8/7/2025 | LS | LS | Used for testing 9/2024 somatic template | |
| Multinodular and vacuolating neuronal tumour | Disease | ||||||||
| Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) | Disease | ||||||||
| Central neurocytoma | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Extraventricular neurocytoma | Disease | ||||||||
| Cerebellar liponeurocytoma | Disease | ||||||||
| Supratentorial ependymoma | Disease | Laveniya Satgunaseelan | 2/4/2026 | 30/6/2026 | PENDING | ||||
| Supratentorial ependymoma, ZFTA fusion-positive | Disease | Laveniya Satgunaseelan | 2/4/2026 | 30/6/2026 | PENDING | ||||
| Supratentorial ependymoma, YAP1 fusion-positive | Disease | Laveniya Satgunaseelan | 2/4/2026 | 30/6/2026 | PENDING | ||||
| Posterior fossa ependymoma | Disease | ||||||||
| Posterior fossa group A (PFA) ependymoma | Disease | ||||||||
| Posterior fossa group B (PFB) ependymoma | Disease | ||||||||
| Spinal ependymoma | Disease | ||||||||
| Spinal ependymoma, MYCN-amplified | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Myxopapillary ependymoma | Disease | ||||||||
| Subependymoma | Disease | ||||||||
CHAPTER 3 (CHOROID PLEXUS TUMOURS) |
|
|
|
|
|
|
|
|
|
| Choroid plexus papilloma | Disease | ||||||||
| Atypical choroid plexus papilloma | Disease | ||||||||
| Choroid plexus carcinoma | Disease | ||||||||
CHAPTER 4 (EMBRYONAL TUMOURS) |
|
|
|
|
|
|
|
|
|
| Medulloblastoma, WNT-activated | Disease | Lisa Lansdon, PhD (LGG trainee just finished);
Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City |
9/20/21 | COMPLETE | Holli Drendel (interim)/Laveniya Satgunaseelan (LS) | 9/22/2022 | 2021 template added | ||
| Medulloblastoma, SHH-activated and TP53-wildtype | Disease | ||||||||
| Medulloblastoma, SHH-activated and TP53-mutant | Disease | Hannah Wollenzien | 1/11/2026 | Pending | MS | ||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Medulloblastoma, non-WNT/non-SHH | Disease | ||||||||
| Medulloblastoma, histologically defined | Disease | ||||||||
| Atypical teratoid/rhabdoid tumour | Disease | ||||||||
| Cribriform neuroepithelial tumour | Disease | ||||||||
| Embryonal tumour with multilayered rosettes | Disease | ||||||||
| CNS neuroblastoma, FOXR2-activated | Disease | ||||||||
| CNS tumour with BCOR internal tandem duplication | Disease | ||||||||
| CNS embryonal tumour NEC/NOS | Disease | ||||||||
CHAPTER 5 (PINEAL TUMOURS) |
|
|
|
|
|
|
|
|
|
| Pineocytoma | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Pineal parenchymal tumour of intermediate differentiation | Disease | ||||||||
| Pineoblastoma | Disease | Fang Fang (trainee)+Katie Schieffer (mentor) | 11/19/2025 | 6/15/2026 | Pending | LS | |||
| Papillary tumour of the pineal region | Disease | ||||||||
| Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant | Disease | ||||||||
CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS) |
|
|
|
|
|
|
|
|
|
| Schwannoma | Disease | See STBT5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Neurofibroma | Disease | See STBT5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Perineurioma | Disease | See STBT5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Hybrid nerve sheath tumours | Disease | See STBT5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Malignant melanotic nerve sheath tumour | Disease | See STBT5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Malignant peripheral nerve sheath tumour | Disease | See STBT5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Cauda equina neuroendocrine tumour (previously paraganglioma) | Disease | ||||||||
CHAPTER 7 (MENINGIOMA) |
|
|
|
|
|
|
|
|
|
| Meningioma | Disease | ||||||||
CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS) |
|
|
|
|
|
|
|
|
|
| Solitary fibrous tumour | Disease | See STBT5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Haemangiomas and vascular malformations | Disease | ||||||||
| Haemangioblastoma | Disease | ||||||||
| Rhabdomyosarcoma | Disease | ||||||||
| Intracranial mesenchymal tumour, FET::CREB fusion-positive | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| CIC-rearranged sarcoma | Disease | See STBT5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Primary intracranial sarcoma, DICER1-mutant | Disease | ||||||||
| Ewing sarcoma | Disease | See STBT5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Mesenchymal chondrosarcoma | Disease | See STBT5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Chondrosarcoma | Disease | ||||||||
| Chordoma | Disease | ||||||||
CHAPTER 9 (MELANOCYTIC TUMOURS) |
|
|
|
|
|
|
|
|
|
| Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis | Disease | ||||||||
| Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma | Disease | ||||||||
CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS) |
|
|
|
|
|
|
|
|
|
| Primary diffuse large B-cell lymphoma of the CNS | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Immunodeficiency-associated CNS lymphomas | Disease | ||||||||
| Lymphomatoid granulomatosis | Disease | See HAEM5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Intravascular large B-cell lymphoma | Disease | See HAEM5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| MALT lymphoma of the dura | Disease | See HAEM5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Other low-grade B-cell lymphomas of the CNS | Disease | ||||||||
| Anaplastic large cell lymphoma (ALK+/ALK−) | Disease | Jennie Thurston | 7/2/2023 | PENDING | MS | 2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)" and "ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)"? | |||
| T-cell and NK/T-cell lymphomas | Disease | ||||||||
| Erdheim-Chester disease | Disease | See HAEM5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Rosai-Dorfman disease | Disease | See HAEM5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Juvenile xanthogranuloma | Disease | See HAEM5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Langerhans cell histiocytosis | Disease | See HAEM5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Histiocytic sarcoma | Disease | See HAEM5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
CHAPTER 11 (GERM CELL TUMOURS) |
|
|
|
|
|
|
|
|
|
| Germ cell tumours of the CNS | Disease | ||||||||
CHAPTER 12 (TUMOURS OF THE SELLAR REGION |
|
|
|
|
|
|
|
|
|
| Adamantinomatous craniopharyngioma | Disease | ||||||||
| Papillary craniopharyngioma | Disease | ||||||||
| Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma | Disease | ||||||||
| Pituitary adenoma / pituitary neuroendocrine tumour | Disease | ||||||||
| Pituitary blastoma | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
CHAPTER 13 (METASTASES TO THE CNS) |
|
|
|
|
|
|
|
|
|
| Metastases to the brain and spinal cord parenchyma | Disease | ||||||||
| Metastases to the meninges | Disease | ||||||||
CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS) |
|
|
|
|
|
|
|
|
|
| Neurofibromatosis type 1 | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Neurofibromatosis type 2 | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Schwannomatosis | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Von Hippel-Lindau syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Tuberous sclerosis | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Li-Fraumeni syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| Cowden syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Constitutional mismatch repair deficiency syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Familial adenomatous polyposis 1 | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Naevoid basal cell carcinoma syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Rhabdoid tumour predisposition syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Carney complex | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| DICER1 syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Familial paraganglioma syndromes | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Melanoma-astrocytoma syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Familial retinoblastoma | Disease | ||||||||
| Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
| BAP1 tumour predisposition syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| Fanconi anaemia | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | |
| ELP1-medulloblastoma syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A |